Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 8 months ago

Possible Interaction: Propafenone and Quinidine

supplement:

Quinidine

Research Papers that Mention the Interaction

Low-dose quinidine may promote the efficacy of propafenone by inhibiting its degradation through the cytochrome P450 pathway (CYP2D6).
Of the 10 refractory patients, 7 were further controlled with a standard dose of propafenone plus quinidine (600 mg/day).
The American journal of cardiology  •  2000  |  View Paper
In this study we tested the hypothesis that quinidine would enhance β‐blockade in extensive metabolizers receiving propafenone.
Subtherapeutic doses of quinidine inhibit P4502D6 and increase plasma propafenone in extensive metabolizer subjects, in whom the active enzyme is present.
Clinical pharmacology and therapeutics  •  1994  |  View Paper
Other antiarrhythmics such as beta-blockers, calcium channel blockers, and amiodarone have been used effectively also; however, some antiarrhythmics such as lidocaine, mexiletine, propafenone , and quinidine may exacerbate neuromuscular symptoms and should be used cautiously.
The Indian Journal of Pediatrics  •  2019  |  View Paper
Throughout the study (follow‐up, 199 ± 155 days), quinidine successfully inhibited CYP2D6: propafenone concentrations were 3 times higher in patients receiving quinidine (1033 ± 611 ng/mL vs 328 ± 229 ng/mL; P < .001).
Journal of clinical pharmacology  •  2012  |  View Paper
In patients with the extensive metabolizer phenotype, quinidine increased mean steady-state plasma propafenone concentrations more than two fold, from 408 +/- 351 (mean +/- s.d.)
British journal of clinical pharmacology  •  1989  |  View Paper
Additive pharmacologic effect can occur when lidocaine, procainamide, and quinidine are combined with propafenone.
Clinical pharmacy  •  1988  |  View Paper
In 30 patients, the addition of propafenone resulted in a significant reduction of premature ventricular contraction (PVC) frequency compared to drug-free baseline (406 PVC/hr vs 33, p less than 0.001) and to procainamide or quinidine monotherapy (211 PVC/hr vs 27, p less than 0.01).
American heart journal  •  1987  |  View Paper
A novel analytical procedure, first beat phasic block determination, provided the opportunity to estimate … single action potential.1.TotalVmax blockade increased in response to the addition of quinidine (1×10−5 mol/l), lidocaine (3×10−5 or … prajmalium (2.5×10−5 mol/l) to a propafenone-containing (….
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper